Literature DB >> 16500997

Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.

Ikuko Mizuta1, Wataru Satake, Yuko Nakabayashi, Chiyomi Ito, Satoko Suzuki, Yoshio Momose, Yoshitaka Nagai, Akira Oka, Hidetoshi Inoko, Jiro Fukae, Yuko Saito, Motoji Sawabe, Shigeo Murayama, Mitsutoshi Yamamoto, Nobutaka Hattori, Miho Murata, Tatsushi Toda.   

Abstract

Parkinson's disease (PD), one of the most common human neurodegenerative diseases, is characterized by the loss of dopaminergic neurons in the substantia nigra of the midbrain. PD is a complex disorder with multiple genetic and environmental factors influencing disease risk. To identify susceptible genes for sporadic PD, we performed case-control association studies of 268 single nucleotide polymorphisms (SNPs) in 121 candidate genes. In two independent case-control populations, we found that a SNP in alpha-synuclein (SNCA), rs7684318, showed the strongest association with PD (P=5.0 x 10(-10)). Linkage disequilibrium (LD) analysis using 29 SNPs in a region around rs7684318 revealed that the entire SNCA gene lies within a single LD block (D'>0.9) spanning approximately 120 kb. A tight LD group (r2>0.85) of six SNPs, including rs7684318, associated most strongly with PD (P=2.0 x 10(-9)-1.7 x 10(-11)). Haplotype association analysis did not show lower P-values than any single SNP within this group. SNCA is a major component of Lewy bodies, the pathological hallmark of PD. Aggregation of SNCA is thought to play a crucial role in PD. SNCA expression levels tended to be positively correlated with the number of the associated allele in autopsied frontal cortices. These findings establish SNCA as a definite susceptibility gene for sporadic PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500997     DOI: 10.1093/hmg/ddl030

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  73 in total

1.  A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease.

Authors:  Lucía F Cardo; Eliecer Coto; Lorena de Mena; René Ribacoba; Oswaldo Lorenzo-Betancor; Pau Pastor; Lluis Samaranch; Ignacio F Mata; Marta Díaz; Germán Moris; Manuel Menéndez; Ana I Corao; Victoria Alvarez
Journal:  J Mol Neurosci       Date:  2011-11-11       Impact factor: 3.444

2.  Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains.

Authors:  Ahmad Jowaed; Ina Schmitt; Oliver Kaut; Ullrich Wüllner
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

3.  SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder.

Authors:  M Toffoli; E Dreussi; E Cecchin; M Valente; N Sanvilli; M Montico; S Gagno; M Garziera; M Polano; M Savarese; G Calandra-Buonaura; F Placidi; M Terzaghi; G Toffoli; G L Gigli
Journal:  Neurol Sci       Date:  2017-04-13       Impact factor: 3.307

4.  Variants in the 3'UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression.

Authors:  Ina Schmitt; Ullrich Wüllner; Jan Pierre van Rooyen; Hassan Khazneh; Julian Becker; Alexander Volk; Christian Kubisch; Tim Becker; Vladimir S Kostic; Christine Klein; Alfredo Ramirez
Journal:  Eur J Hum Genet       Date:  2012-05-23       Impact factor: 4.246

5.  The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

Authors:  Jeanette J McCarthy; Colton Linnertz; Laura Saucier; James R Burke; Christine M Hulette; Kathleen A Welsh-Bohmer; Ornit Chiba-Falek
Journal:  Neurogenetics       Date:  2010-11-03       Impact factor: 2.660

Review 6.  Aging stem cells, latexin, and longevity.

Authors:  Ying Liang; Gary Van Zant
Journal:  Exp Cell Res       Date:  2008-02-19       Impact factor: 3.905

Review 7.  Progress in the pathogenesis and genetics of Parkinson's disease.

Authors:  Yoshikuni Mizuno; Nobutaka Hattori; Shin-Ichiro Kubo; Shigeto Sato; Kenya Nishioka; Taku Hatano; Hiroyuki Tomiyama; Manabu Funayama; Yutaka Machida; Hideki Mochizuki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

8.  The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease.

Authors:  Colton Linnertz; Michael W Lutz; John F Ervin; Jawara Allen; Natalie R Miller; Kathleen A Welsh-Bohmer; Allen D Roses; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2014-04-28       Impact factor: 6.150

9.  Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.

Authors:  Lidia Tagliafierro; Omolara-Chinue Glenn; Madison E Zamora; Thomas G Beach; Randy L Woltjer; Michael W Lutz; Ornit Chiba-Falek
Journal:  Alzheimers Dement       Date:  2017-04-18       Impact factor: 21.566

10.  Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease.

Authors:  Ikuko Mizuta; Tatsuhiko Tsunoda; Wataru Satake; Yuko Nakabayashi; Masahiko Watanabe; Atsushi Takeda; Kazuko Hasegawa; Kenji Nakashima; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Tatsushi Toda
Journal:  Hum Genet       Date:  2008-06-22       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.